About this trial
Urinary stone disease is a common urological condition that affects millions of people worldwide, often leading to significant morbidity and healthcare costs. Medium-sized renal stones, typically defined as stones measuring 1 to 2 cm in diameter, pose a particular challenge in management. These stones are large enough to potentially cause significant obstruction and symptoms, yet their size and location make selecting an optimal treatment modality crucial for achieving favorable outcomes with minimal complications.
Historically, open surgery was the primary intervention for large or complex stones. However, the advent of minimally invasive techniques has revolutionized stone management, allowing for more effective and patient-friendly approaches. Among these, Super-mini percutaneous nephrolithotomy (SMP), flexible uretero-renoscopy (F-URS), and shock wave lithotripsy (SWL) have emerged as minimally invasive modalities for managing medium-sized renal stones.
This study aims to evaluate the outcomes; safety, efficacy, and complications associated with SMP versus F-URS Versus SWL in the management of reanl stones 10-20 mm in diameter.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients (≥ 18 years old)
Single renal stones 10-20 mm in longest dimension
Disqualifiers
Previous upper urinary tract exploration in ipsilateral side.
Patients with JJ stent in ipsilateral side.
Absolute contraindications to SWL
Trial design
Parallel
Treatments tested in this trial
Modified Tubeless Super-Mini Percutaneous Nephrolithotomy
Procedure/SurgeryModified Tubeless Super-Mini Percutaneous Nephrolithotomy
Flexible Ureterorenoscopy
Procedure/SurgeryFlexible Ureterorenoscopy
Shockwave Lithotripsy
Procedure/SurgeryShockwave Lithotripsy
Treatment groups
Trial outcomes
Primary outcomes
Stone free rate
1\. SFR (by MSCT KUB) a patient is considered stone-free if the remaining fragments are less than 3 mm in size after 3 months of the procedure
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: